| 糖尿病合并亚临床甲状腺功能减退症及其对动脉粥样硬化的影响 |
| |
| 引用本文： | 杜海梅,王娜,张永莉. 糖尿病合并亚临床甲状腺功能减退症及其对动脉粥样硬化的影响[J]. 中国动脉硬化杂志, 2018, 26(3): 315-320 |
| |
| 作者姓名： | 杜海梅 王娜 张永莉 |
| |
| 作者单位： | 延安大学附属医院; |
| |
| 摘 要： | 糖尿病大血管病变是糖尿病发病率最高、危害性最大、致死率最高的并发症。亚临床甲状腺功能减退症是以正常甲状腺素水平和升高的促甲状腺激素水平为特征的一种轻度或补偿型原发性甲状腺功能减退症。近年来国内研究显示升高的促甲状腺激素可作为动脉粥样硬化的独立危险因素,通过多种途径促进动脉粥样硬化的发展,从而参与糖尿病大血管病变的进展。文章通过参考总结相关文献将亚临床甲状腺功能减退与糖尿病患者动脉粥样硬化之间的相关性作一综述。
|
| 关 键 词： | 糖尿病 亚临床甲状腺功能减退症 动脉粥样硬化 |
| 收稿时间： | 2017-08-06 |
| 修稿时间： | 2017-11-26 |
Diabetes mellitus combined with subclinical hypothyroidism and its impact on atherosclerosis |
| |
| DU Hai-Mei,WANG Na and ZHANG Yong-Li. Diabetes mellitus combined with subclinical hypothyroidism and its impact on atherosclerosis[J]. Chinese Journal of Arteriosclerosis, 2018, 26(3): 315-320 |
| |
| Authors: | DU Hai-Mei WANG Na ZHANG Yong-Li |
| |
| Affiliation: | The Affiliated Hospital of Yan''an University, Yan''an, Shaanxi 716000, China,The Affiliated Hospital of Yan''an University, Yan''an, Shaanxi 716000, China and The Affiliated Hospital of Yan''an University, Yan''an, Shaanxi 716000, China |
| |
| Abstract: | Diabetic macrovascular disease is a complication of diabetes,with the highest incidence,the most harmful and the highest death rate. Subclinical hypothyroidism (SCH) is defined as a plasma thyroid-stimulating hormone (TSH) level above the institutional reference range combined with a plasma free thyroxine (FT4) or free triiodothyronine (FT3) level. In recent years, domestic studies have shown that elevated TSH can be used as an independent risk factor for atherosclerosis (As) through a variety of ways to promote the development of As, and thus participate in the progress of diabetic macroangiopathy. This article reviews the association between SCH and atherosclerosis in diabetic patients by summarizing the relevant literature. |
| |
| Keywords: | Diabetes mellitus Subclinical hypothyroidism Atherosclerosis |
| 本文献已被 CNKI 等数据库收录！ |
| 点击此处可从《中国动脉硬化杂志》浏览原始摘要信息 |
|
点击此处可从《中国动脉硬化杂志》下载全文 |
|
